Found "Public health policy": 1,082 results
Mission Report: Revising Basic Health Benefit Package for Social Health Insurance 19 – 20 April 2016
Vietnam is one of the countries that are on the journey to achieve Universal Health Coverage (UHC). With the Health Insurance Law enacted in 2008, and master plan for UHC approved by the prime minister in 2012, health insurance coverage has been continuously developed both in terms of population and
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh (2016)
Background
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li
Economic evaluation of an integrated care on delaying chronic kidney disease progression in rural communities of Thailand
In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.
Research Proposal: Economic evaluation of an integrated care on delaying chronic kidney disease progression in rural communities of Thailand
In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht f
Center for Global Development launched a report on “Priority-Setting in Health: Building institutions for smarter public spending”
“Health donors, policymakers, and practitioners continuously make life-and-death decisions about which type of patients receive what interventions, when, and at what cost. These decisions—as consequential as they are— often result from ad hoc, nontransparent processes driven more by inertia
iDSI launches global public good: questionnaire on priority-setting readiness
iDSI aims to help policymakers in low and middle income countries in building capacity for active priority-setting, such that they can spend limited health budgets in a more efficient and equitable way, and achieve sustainable universal health coverage (UHC). In order to help achieve iDSI this aim,
The Lancet Commission for Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases
Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d
Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. (2010)
Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences.
Rob Baltussen1, Sitapon Youngkong11,2, Francesco Paolucci3, Louis Niessen4
1 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands
2 Health I
Evaluating HITAP: 2 years on
\"First Step”, a program evaluation report, assessing HITAP’s two-year efforts and providing recommendations for further development of HITAP. This program evaluation was conducted by four external evaluators including Prof. John Cairns, Dr. Kalipso Chalkidou, Prof. Paibul Suriyawongpaisal, and Dr. Jirawat Panpiemras. Moreover, Prof. Mark Sculp
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
Abstract
BACKGROUND:
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) th
10 / Page